The dynamics of virological and serological indices in primary herpetic keratitis in rabbits treated with antiviral drugs.
D000818:Animals; D000917:Antibody Formation; D000998:Antiviral Agents / Q000627:therapeutic use*; D003228:Conjunctiva / Q000276:immunology / Q000382:microbiology; D004195:Disease Models, Animal; D005455:Fluorescent Antibody Technique; D007369:Interferon Inducers / Q000627:therapeutic use; D007635:Keratitis, Dendritic / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control; D008070:Lipopolysaccharides / Q000627:therapeutic use; D009500:Neutralization Tests; D010919:Placebos; D011063:Poly A-U / Q000627:therapeutic use; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011817:Rabbits; D012485:Salmonella typhi; D012672:Semliki forest virus; D018139:Simplexvirus / Q000276:immunology / Q000302:isolation & purification; D005719:gamma-Globulins / Q000627:therapeutic use
D000998:Antiviral Agents; D007369:Interferon Inducers; D008070:Lipopolysaccharides; D010919:Placebos; D011135:Polysaccharides, Bacterial; D005719:gamma-Globulins; D011063:Poly A-U; D011239:Prednisolone